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Background: In Australia, community-associated methicillin-resistant Staphylococcus
aureus (MRSA) lineage sequence type (ST) 93 has rapidly risen to dominance since
being described in the early 1990s. We examined 459 ST93 genome sequences from
Australia, New Zealand, Samoa, and Europe to investigate the evolutionary history of
ST93, its emergence in Australia and subsequent spread overseas.
Results: Comparisons with other S. aureus genomes indicate that ST93 is an early
diverging and recombinant lineage, comprising of segments from the ST59/ST121
lineage and from a divergent but currently unsampled Staphylococcal population.
However, within extant ST93 strains limited genetic diversity was apparent with the
most recent common ancestor dated to 1977 (95% highest posterior density 1973–
1981). An epidemic ST93 population arose from a methicillin-susceptible progenitor
in remote Northern Australia, which has a proportionally large Indigenous population,
with documented overcrowded housing and a high burden of skin infection. Methicillin-
resistance was acquired three times in these regions, with a clade harboring a
staphylococcal cassette chromosome mec (SCCmec) IVa expanding and spreading to
Australia’s east coast by 2000. We observed sporadic and non-sustained introductions
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of ST93-MRSA-IVa to the United Kingdom. In contrast, in New Zealand, ST93-MRSA-
IVa was sustainably transmitted with clonal expansion within the Pacific Islander
population, who experience similar disadvantages as Australian Indigenous populations.
Conclusion: ST93 has a highly recombinant genome including portions derived from an
early diverging S. aureus population. Our findings highlight the need to understand host
population factors in the emergence and spread of antimicrobial resistant community
pathogens.
Keywords: Staphylococcus aureus, MRSA, community-associated, ST93, evolution, Aboriginal, Indigenous
INTRODUCTION
Over the past two decades multiple clones of community-
associated methicillin-resistant Staphylococcus aureus (CA-
MRSA) have emerged globally (DeLeo et al., 2010). These
distinct CA-MRSA lineages have arisen almost simultaneously
in different regions of the world. Although the pathogen-specific
factors contributing to this phenomenon continue to be sought,
a common characteristic is that particular host populations
have been identified as risk groups for CA-MRSA infections
and/or carriage. These populations tend to be socio-economically
marginalized with Indigenous, injecting drug user, incarcerated
and homeless populations being overrepresented. For example,
USA300 infections in the United States were first reported in
children in disadvantaged populations in Chicago (Herold et al.,
1998), while CA-MRSA in Australia were initially documented
from Indigenous populations in Western Australia (Udo et al.,
1993). This association is further supported when examining
ST80-MRSA emergence in Europe with infections occurring in
children from lower socio-economic households (Dufour et al.,
2002).
In contrast to healthcare-associated MRSA lineages,
which have demonstrated intercontinental transmission with
subsequent establishment and spread within local healthcare
systems (Harris et al., 2010; Holden et al., 2013), the typical
pattern of movement for CA-MRSA lineages appears to be far
more geographically restricted. Despite frequent intercontinental
traffic between North America and Europe, the dominant
USA300 CA-MRSA lineage has not become established in
Europe (Toleman et al., 2016; Bouchiat et al., 2017). Similarly,
ST80-MRSA in Europe, which likely arose from a methicillin-
susceptible S. aureus (MSSA) ancestor from sub-Saharan
Africa (Stegger et al., 2014), has not become established in the
United States. Frequent intercontinental transfers have also been
noted for the South-East Asian CA-MRSA clone (ST59), but
with limited evidence of ongoing clonal transmission outside the
country of origin (Ward et al., 2016).
In Australia, the dominant CA-MRSA lineage is the Panton–
Valentine leukocidin positive ST93. First reported in the early
2000s in Queensland on the eastern coast of Australia (Munckhof
et al., 2003), ST93-MRSA has rapidly become the most common
circulating CA-MRSA lineage (Coombs et al., 2016). Severe
clinical manifestations have been widely reported (Peleg et al.,
2005; Tong et al., 2008). Murine models suggest ST93 to be more
virulent than other CA-MRSA clones including USA300 (Chua
et al., 2011; Tong et al., 2013). Previous investigations of ST93
genomics by Stinear et al. (2014) demonstrated limited genetic
diversity of the clone, with acquisition of staphylococcal cassette
chromosome mec element (SCCmec) conferring methicillin-
resistance on two occasions. Dating and phylogeographical
analyses concluded that the most recent common ancestor
of ST93 MSSA included in that study arose in the 1970s in
North Western Australia. These conclusions were based on a
collection of 56 isolates predominantly from Western Australia
(representing approximately half of all the isolates). Given
these limitations, and the current uncertainty of the ancestry
of ST93 relative to other S. aureus lineages, we examined the
genomics of ST93 on an extended dataset (consisting of an
additional 403 ST93 isolates). This collection not only represents
a deeper sampling from the hypothesized regions of emergence
in Australia, but also a broader sampling from non-Australian
regions to encompass the presumed international spread of ST93-
MRSA. We describe the relationship of ST93 to other S. aureus
lineages and impact of recombination on its genome, as well as
the emergence of ST93 as a successful MSSA and subsequent
CA-MRSA lineage from remote sparsely populated regions of
Northern Australia.
MATERIALS AND METHODS
Isolate Collection
Overall 459 sequenced S. aureus isolates were included in the
study. We set out to capture as much diversity as practicable of
ST93, and in so doing, established for whole-genome sequencing
a collection of 403 presumed ST93 S. aureus (based on local
typing schemes) from international locations where ST93 has
been reported including Australia, New Zealand, Samoa, and five
European countries (Supplementary Table S1). All isolates were
from patients with invasive and non-invasive infections collected
between 1991 and 2012 and confirmed as either MSSA or MRSA.
The data were supplemented by sequence reads from a further
56 isolates, sequenced as part of a previous study by Stinear
et al. (2014). Metadata details can be found in Supplementary
Table S1.
Sequencing and Assembly
Genomic DNA samples were sequenced on the Illumina
HiSeq 2500 platform using 151b paired-end TruSeq chemistry.
Reads were mapped to the complete JKD6159 reference
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genome (2,811,435 bp, GenBank: NC017338), an ST93-MRSA-
IVa isolated from a patient in Melbourne, Australia in 2004
(Chua et al., 2010) using SMALT. Variants were called using a
combination of Samtools mpileup1 and bcftools2 with filtering
for read depth, read base quality, and mapping quality, ensuring
only high-quality SNPs were accepted. All variants at either
indels or secondary to mobile elements were excluded from the
mapping-based analysis.
The Relationship of ST93 Relative to
Other S. aureus Lineages
Manually completed genomes of S. aureus were obtained
from the NCTC3000 reference collection3 using nctc-tools4 and
supplemented with reference sequences from NCBI including
the MSHR1132 genome assembly of Staphylococcus argenteus
(Supplementary Table S2). Multi-locus sequence types (MLST)
were assigned with mlst5 and GFF files were generated with
a standardized re-annotation of the collection with Prokka
(Seemann, 2014). The whole-genome alignment consisted of
extracted locally collinear blocks (LCBs) of 500 bp, present
in all genomes determined by progressiveMauve (Darling
et al., 2010) and ordered against the ST93 reference genome.
Recombination in the core genome alignment was detected with
Gubbins (Croucher et al., 2015). Pre- and postrecombination
maximum-likelihood phylogenies (under the GTR+G model)
were generated from the SNP matrices [determined using SNP-
sites (Page et al., 2016) and from variant sites determined by
Gubbins] employing RAxML-NG v.0.56 with the S. argenteus
genome MSHR1132 as outgroup and 100 bootstrap replicates.
Resultant phylogenies were visualized in Interactive Tree of
Life (Letunic and Bork, 2016). The identity and total number
of unique sites affected by recombination was computed by
taking the set of base pair locations present in all recombinant
segments for a lineage. Recombination events were filtered
by size and visualized against the respective non-recombinant
phylogeny with plotTree7. To test the accuracy of the results,
the aforementioned workflow was repeated using Mugsy instead
of progressiveMauve to establish the core genome alignment
(Angiuoli and Salzberg, 2011). Similar results were obtained
throughout. Nucleotide divergences were computed on the
ProgressiveMauve alignment over a non-overlapping 10,000 bps
sliding window under the K80 model of evolution in the dist.dna
function of ape for R.
Phylogenetic Dating
To investigate the temporal evolution of ST93 we used the
Bayesian software package BEAST2 (v.2.3) on the 459 ST93
genomes (Bouckaert et al., 2014). A GTR substitution model with
gamma correction for among-site variation was implemented
1http://samtools.sourceforge.net
2https://samtools.github.io/bcftools/
3http://sanger.ac.uk/resources/downloads/bacteria/nctc/
4https://github.com/esteinig/nctc-tools
5https://github.com/tseemann/mlst
6https://github.com/amkozlov/raxml-ng
7https://github.com/katholt/plotTree
using the core genome following masking of homologous
recombination identified by Gubbins (Croucher et al., 2015). All
combinations of strict, relaxed lognormal, relaxed exponential
and random clock models and constant, exponential and
skyline population models were evaluated. Models which failed
to converge or result in an effective sample size values
<200 following 100 million generations, sampling every 1,000
generations, were excluded from further comparison. The best-
fit model combination, exponential population with a relaxed
lognormal clock model, was determined by marginal likelihoods
using the smoothed harmonic mean estimator within the
program Tracer v.1.4. A maximum clade credibility tree was
created using the treeAnnotator program. Phylogenetic trees
were visualized and manipulated with Figtree v1.4.28.
Phylogenetic Clustering
To determine clusters in the phylogeny, mutual k-nearest
neighbor population graphs (mkNNG) were constructed from
the cophenetic distances of the BEAST2 phylogeny using package
ape for R and NetView (Neuditschko et al., 2012; Steinig
et al., 2016) with a range of k = 1–100. Fast-greedy modularity
optimization (Clauset et al., 2004) Walktrap (Pons and Latapy,
2005) and Infomap (Rosvall and Bergstrom, 2010) algorithms
were run on each network configuration to define communities in
the graph topology. To assess the stability of the communities in
the network topology and select an appropriate configuration, the
number of detected communities (n) was plotted against k. The
plot indicated a disassociation of the community structure (in line
with increasing sparseness of edges) in the network at k < 10.
Communities found in a conservative and stable configuration
of the network (k = 60, vertices = 459, edges = 4,711) were
selected to determine the general network clusters using the
low-resolution fast-greedy modularity optimization algorithm
(Supplementary Figure S7). Cluster assignments were mapped
back to the phylogeny (Supplementary Figures S7A,B).
Global and Regional Transmission
Routes
A Bayesian phylogeographic analysis was performed within
BEAST2 using the longitude and latitude data from where the
sequenced isolate originated (Lemey et al., 2009). Subsequent
data were visualized and manipulated in the software tool
SPREAD (Bielejec et al., 2011). In addition, ML Ancestral state
reconstruction was undertaken to confirm the likely origin of
ST93 treating isolate location as a discrete trait in R package ape.
Skyline population models were examined but excluded as they
were found to be biased by non-uniform sampling.
SCCmec Analysis
Alignment of de novo contigs to the reference (JKD6159)
SCCmecIV[2B] revealed two additional SCCmec types. Assembly
and closure of a novel SCCmec type was achieved by
mapping contigs to previously described elements and Sanger
sequencing to bridge sequence gaps. The variant was referred
8http://tree.bio.ed.ac.uk/software/figtree
Frontiers in Microbiology | www.frontiersin.org 3 July 2018 | Volume 9 | Article 1453
fmicb-09-01453 July 9, 2018 Time: 11:56 # 4
van Hal et al. Global Dissemination of ST93 S. aureus
to the International Working Group on the Classification of
Staphylococcal Cassette Chromosome Elements (IWG-SCC)
which confirmed the new variant, named SCCmecIVn. Two
“discordant” isolates (from NZ and Victoria) were detected (i.e.,
mecA negative but phenotype reported as methicillin-resistant).
Sequence mapping to SCCmec confirmed reads mapping to the
components of the cassette suggesting these isolates had lost
components of their SCCmec, a phenomenon known to occur
with storage (van Griethuysen et al., 2005).
Pan-Genome and Genomic Association
A pan-genome was created from isolate contigs, which were
generated with an in-house assembly and improvement pipeline
based on Velvet (Zerbino, 2010) and annotated using Prokka
(Seemann, 2014). The pan-genome was generated using Roary
(Page et al., 2015) and visualized using Phandango (Hadfield
et al., 2017).
Nucleotide Sequence Accession Number
The sequence reads for all isolates are available from ENA
(Supplementary Table S1).
RESULTS
ST93 Is a Divergent and Recombinant
S. aureus Lineage
The position of ST93 within the S. aureus population structure
has never been clearly defined. Indications from multilocus
sequence typing loci are that ST93 diverged early from other
S. aureus but was not ancestral to ST121 or ST59 (Tong et al.,
2010). In contrast, when using the entire shared core genome,
a maximum likelihood phylogeny places ST93 as the earliest
diverging lineage from all other S. aureus genomes included
in this study, with a bootstrap support of 100% (Figure 1A).
However, after masking of putative recombined regions in
the core genome (21.6% in ST93), ST93 was no longer the
earliest diverging S. aureus lineage. Instead, it was placed within
the broader clade containing ST59 and ST121 (Figure 1B).
We examined the putative recombinant regions and found no
evidence for a large recombined region event, unlike ST239 which
has a single chromosomal replacement of ∼600 kb (Robinson
and Enright, 2004), but rather evidence for numerous short
segments with an average length of 2,209 bp (Supplementary
Figures S1, S2). More than half of the recombinant regions were
unique to the ST93 branch and not shared with other lineages
(Supplementary Figures S1, S2B). Such terminal recombination
events were more common and their contribution to nucleotide
variation greater in ST93 compared to other S. aureus genomes
[as measured by the recombination/mutation ratio (r/m) of 1.96
and the number of recombination events to point mutation
ratio (ρ/θ) of 0.0167; Supplementary Figures S2C,D]. When we
examined pair-wise nucleotide divergence of the core genome
for the S. aureus species we found that for some regions ST93
was equally and highly diverged from the two main branches
of S. aureus as represented by ST59 and ST8 strains (Figure 1C
and Supplementary Figure S3). The genomic location of
these divergent regions correlated with the regions of terminal
recombination events detected by Gubbins and included several
complete coding regions (Supplementary Table S3). For other
regions, the pairwise ST93↔ST59 distance was considerably
less than the ST93↔ST8 distance and was similar to that
of ST59↔ST121. Thus, ST93 has been heavily impacted by
recombination, with large parts of its genome showing a
specific relationship with the ST59/ST121 group, and other parts
descended from S. aureus lineages earlier diverging than any of
the genomes in this study.
ST93 Emerged From North-Western
Australia Within the Last 50 Years
We determined the phylogenetic structure of a geographically
diverse collection of 459 ST93 isolates, which included MSSA
(n = 112) and MRSA (n = 347) (Figure 2). The isolates represent
an unbiased sampling of S. aureus recovered from community
and hospital onset skin infections in the Northern Territory
(McDonald et al., 2006; Tong et al., 2010), MRSA strains from
hospitals and reference collections from Australia, and MRSA
strains from public health collections in Europe (mainly the
United Kingdom) and New Zealand (Supplementary Table S1
and Supplementary Figure S4). There were 7,044 core genome
SNP-sites among the 459 isolates.
Dating of the root of the tree (Figure 2) suggests the most
recent common ancestor of currently extant ST93 isolates to
be 1977 [95% highest posterior density (HPD) 1973–1981; and
a mutation rate of 1.05 × 10−6 (95% HPD 9.8 × 10−7 to
1.12 × 10−6)]. The ST93-MSSA isolates form a clear basal
group, with the vast majority of MSSA isolates (n = 104/112),
including the most basal MSSA isolates, originating from the
bordering jurisdictions of the Northern Territory and Western
Australia (Figure 2C). Ancestral state reconstruction strongly
supports an origin of ST93-MSSA from North Western Australia
(Figure 3) with the probability heavily weighted toward a
Northern Territory origin rather than Western Australia.
Methicillin Resistance Emerged in ST93
on At Least Three Occasions
Within this diverse MSSA population, SCCmec has been acquired
on at least three occasions (Figure 2). The acquisition of a
type IVa SCCmec element (SCCmecIVa), in the late 1980s
or early 1990s, was the basis for a large clonal expansion
event, encompassing 332/345 (96.2%) of the MRSA isolates
in the study (two isolates were phenotypically MRSA but
genotypically lacking mecA). A single isolate from Western
Australia harbored a type V SCCmec element (SCCmecV).
A separate cluster, consisting of 12 isolates from the Northern
Territory was found to harbor a novel SCCmec element
(GenBank Accession Number KX385846) (Figure 4), now
designated IVn (SCCmecIVn; International Working Group
on the Classification of Staphylococcal Cassette Chromosome
Elements). The 12 isolates formed a monophyletic cluster,
representing a separate and distinct acquisition event, within
the Northern Territory. Of the 12 isolates, 11 were spa type
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FIGURE 1 | Phylogenetic position of ST93 in relation to other Staphylococcus aureus. Maximum-likelihood cladograms (RAxML, GTR+G) generated from complete
reference genomes from a core alignment with progressiveMauve before (A) and after (B) removing recombination with Gubbins. Red branches indicate branches
with bootstrap support of 100 and indicate strong support for an early divergence of ST93 (indicated by the blue branch) outside the main group of S. aureus
sequence types (A). Following masking of recombination, ST93 is located within the larger S. aureus complex basal to a larger clade containing other regional clones
like ST59 and ST121 (B). Colored boxes around tip labels indicate isolate pairs used in subsequent comparisons. (C) Pair-wise nucleotide divergence across a
10,000 bp sliding window along the S. aureus core genome with comparisons between ST59-ST121, ST93-ST59, and ST93-ST8. Bases affected by recombination
as detected by Gubbins across the ST93 genome are represented above with shared ancestral events (red) and events unique to the ST93 terminal branch (blue).
Terminal branch recombination regions align with genomic positions where ST93 is highly diverged compared to other S. aureus.
t202, which is the majority spa type in the entire dataset
(346/459) and 1 was spa type t1811. These two spa types
differ by the presence of one repeat (t202, 11-17-23-17-16-16-
25; t1811, 11-17-17-16-16-25). SCCmecIVn is closely related
to SCCmecIVa of the reference strain JKD6159 (ST93-MRSA-
IVa), and shares >98% nucleotide identity apart from a
pUB110 insertion flanked by IS431 elements in the J3 region
of SCCmecIVn (Figure 4). The pUB110 element displays
>99% identity to pUB110 in the type II SCCmec elements
(SCCmecII) from Mu3, Mu50, MRSA252, and JKD6008, and
contains an ant4-1/aadD aminoglycoside resistance gene that has
been described to confer high-level resistance to tobramycin,
amikacin, and kanamycin, as well as the bleomycin resistance
gene, bleO.
The geographical origins of the ST93-MRSA-IVa lineage have
to date remained unclear. ST93-MRSA-IVa was first described
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FIGURE 2 | ST93 phylogeny. Maximum clade credibility tree obtained from the core genome not affected by recombination of 459 ST93 sequences using BEAST2.
x-Axis depicts time in years. Metadata from left to right indicate the presence or absence of the mecA gene by SCCmec type (i.e., methicillin resistance; white –
absence, red – SCCmecIVa, brown – SCCmecIVn, light blue – SCCmecV), the region of origin, and clustering based on the network analysis. Three regions of
interest are magnified to the right of the tree with associated metadata. (A) Corresponds with group 5 containing predominantly isolates from New Zealand (see text
for details). (B) Acquisition events of SCCmecIVa and SCCmecV elements leading to the establishment of ST93-MRSA-IVa. (C) The likely origin of ST93 showing the
earliest basal strains of ST93-MSSA leading into the main MSSA group. Letters, black filled circles, and solid triangles (collapse point of the rest of the tree) allow for
correlation of inserts with the total phylogeny. NZ, New Zealand; EU, Europe; NSW, New South Wales; NT, Northern Territory; QLD, Queensland; VIC, Victoria; WA,
Western Australia. Australian Capital Territory (n = 1) and South Australian (n = 2) isolates are included with NSW and Victorian isolates, respectively.
in South East Queensland in 2000 as a cause of skin and soft
tissue infections (SSTI) in mainly Caucasian patients (Munckhof
et al., 2003), and then in 2003 as a cause of severe disease in
mostly Indigenous Australian patients (Peleg et al., 2005). In
our dataset, the earliest ST93-MRSA-IVa strains were isolated in
2000, and eight of these nine strains, were from the eastern states
of Australia (New South Wales/Australian Capital Territory:
SAPWH23, SAPWH39, SAPRPAH96, SAPTCH92, SAPWH61,
SAPWH64; Queensland: SAPRBH98; Victoria: SAPRCH74; and
South Australia: SAPGPSA73). Notably, despite comprehensive
state-wide typing of MRSA isolates since 1996 in Western
Australia, ST93-MRSA was not identified in Western Australia
until 2003. Ancestral state reconstruction (Figure 3) indicates
that the ST93-MRSA-IVa lineage most likely emerged from
the Northern Territory in the early 1990s. By the year 2000,
transmission from the Northern Territory to the eastern states
of Queensland and New South Wales had occurred.
International Transmission of
ST93-MRSA-IVa
Network clustering delineated five main ST93 groups: Groups
1 and 2 representing MSSA strains and groups 3, 4, and 5
representing the three major groups within the ST93-MRSA-IVa
clade (Figure 2). Group 3 is principally comprised of strains from
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FIGURE 3 | ST93 geographic origins. Ancestral state reconstruction based on
maximum clade credibility tree generated using BEAST2 with geographic
regions as discrete traits. Each node indicates the log likelihood for specified
locations as the origin of the node in pie chart format. Pie charts
corresponding with the origins of (1) MSSA and (2) MRSA are enlarged for
easier visualization. Abbreviations and colors for regions are as per Figure 2.
FIGURE 4 | Novel SCCmecIVn. Sequence comparison of regions of
homology between SCCmecII and IV elements from isolates Mu3 (green),
ST93 JDK6519 (purple), and the new consensus SCCmecIVn from ST93
(blue). Mu3 carries SCCmecII and mec complex A, JKD6159 SCCmecIVa and
mec complex B, and the novel SCCmecIVn is also mec complex B. Inner
rings denote coding regions (orange – transposition; red – resistance; dark
gray – SCCmec characteristic regions orfX, mec cassette and ccr complex;
light gray – other). Chords denote major regions (mec, ccr, pUB110) defined
by nucleotide BLAST comparisons (>99% identity and >1 kb) of SCCmecII
and IV elements against the SCCmecIVn.
the Australian east coast (81/105 strains are from New South
Wales, Australian Capital Territory, Victoria, South Australia,
and Queensland) and Europe.
European isolates (mainly from the United Kingdom)
are highly diverse and are scattered across groups 3, 4,
and 5 consistent with multiple sporadic exportations to
the United Kingdom (and possibly elsewhere in Europe).
Despite frequent exportation events and a limited number
of transmission chains within the United Kingdom
[Supplementary Figure S5; with one cluster of three isolates
originating from the same pediatric hospital (Supplementary
Figure S5 – Box 2) and one cluster of four isolates recovered
from an index case and siblings in the same household
(Supplementary Figure S5 – Box 1)], no evidence for sustained
transmission in the United Kingdom was seen.
In contrast to the epidemiological picture in Europe, there was
evidence for sustained transmission and endemic spread of ST93-
MRSA-IVa in New Zealand. The majority of New Zealand isolates
cluster together within group 5 (Figure 2). This strongly suggests
establishment in around 2000 followed by clonal expansion
and sustained transmission of a New Zealand specific ST93-
MRSA-IVa lineage. In addition, not only is there evidence
of ongoing transmission in New Zealand, but also instances
of transmission back to Australia and to Europe. Given the
novelty of this observation with respect to CA-MRSA lineages
(i.e., introduction and establishment of a CA-MRSA lineage),
we examined the epidemiological characteristics associated with
these New Zealand isolates. Significantly, 52% (28/54) of all
ST93-MRSA-IVa from New Zealand [or 63% (25/40) of group
5] were centered around Auckland on the north island and
principally originating from within the Ma¯ori and Pacific
Islander populations [of New Zealand isolates with a known
host ethnicity, 32/49 (65%) of ST93-MRSA-IVa overall, and
24/38 (63%) of group 5, were recovered from Ma¯ori and Pacific
Islanders]. A Spatial Phylogenetic reconstruction (Figure 5)
supported transmissions between Australia and New Zealand via
hosts of European or unknown ethnicity, while the majority of
within New Zealand transmission was within the Pacific Islander
population.
The contrast between the epidemiology in the
United Kingdom and New Zealand is further supported by
the longitudinal data (Supplementary Figure S6) based on
contemporary MRSA typing results (between 2008 and 2015)
from the United Kingdom, New Zealand and Australia, which
indicate consistently low levels of ST93 in the United Kingdom
and therefore likely ongoing sporadic importation, compared
to continued increases in Australia and New Zealand consistent
with sustained transmission and endemic spread within these
two countries.
Genomic Markers of Specific Clades
We examined the dataset for genetic markers that may provide
clues to the success of specific clades within the overall ST93
population. Twelve single nucleotide variants (SNVs) mapped
to the branch corresponding to SCCmecIVa acquisition, of
which 11 SNVs were not associated with known virulence
genes. One SNV introduced a premature stop codon in aryK,
a novel virulence regulator as previously described by Chua
et al. (2014). It has been hypothesized that this loss-of-function
point mutation may act to reduce the virulence of ST93 and
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FIGURE 5 | Transmission of ST93-MRSA-IVa in Australia and New Zealand.
Phylogenetic diffusion of ST93 within New Zealand based on discrete traits
implemented using SpreaD3. Oceania region is depicted with the outlined
area (New Zealand) enlarged in insert B. White open circles represent the
origin of the isolate. For isolates from the same location a jiggle factor is
included such that intra-local diffusion is visible. Connecting colored lines
represent the ethnicity of the host as shown in the legend. Circular polygons
are proportional to the number of tree lineages maintaining that location.
Indigenous ethnicity reflects either an Aboriginal Torres Strait Islander
(Australian) or Maori (New Zealand) host. The analysis shows that within
New Zealand maintenance of ST93 is centered on Auckland within the Maori
and Pacific Islander communities and that introductions of this clone are
linked to travel between New Zealand and Australia.
contribute to host persistence. However, the ongoing circulation
of ST93-MSSA in the Northern Territory suggests that ST93 is
quite capable of successful persistence despite the lack of an
SCCmec element and the absence of this loss-of-function point
mutation.
We also looked at variants restricted to the New Zealand
clade (group 5) (Supplementary Table S4). Fourteen SNVs
were found of which eight were non-synonymous. Of note, a
mutation in adsA (also known as sasH), encoding a surface
bound protein adenosine synthase, was detected. AdsA is a critical
virulence factor in S. aureus and converts adenosine tri-, di-, and
monophosphate to adenosine, facilitating escape from phagocytic
clearance (Lemey et al., 2009; Bielejec et al., 2011). However, the
P33S substitution conferred by the mutation sits outside both
the metallophosphatase and 5′-nucleotidase conserved domains
of adsA, and thus the functional implications of this mutation
with regards to fitness or virulence are unknown, and will require
further laboratory experiments to elucidate.
The overall ST93 gene content (pan-genome) consisted of
3,837 genes, of which the core genome (present in over 99% of
isolates) comprised 2,436 genes. Of the remaining 1,401 genes
outside of the core genome, 1,212 were found in <15% of
isolates, consistent with a significant flux of accessory genes.
Apart from genes associated with SCCmec elements, we did not
find associations between particular accessory genome elements
and the major clades. 455/459 isolates harbored the PVL genes
lukS-PV and lukF-PV. The Roary output for the pan-genome can
be found in Supplementary Table S5.
DISCUSSION
The evolutionary history of ST93 represents the emergence from
isolated and sparsely populated regions in Australia of a virulent
community-associated S. aureus lineage, which has become
established more broadly in Australia. Global transmission has
also occurred in different patterns, with sporadic transmission to
the United Kingdom and elsewhere in Europe and contrastingly,
sustained endemicity in the New Zealand Pacific Island
population. These findings suggest that as much as pathogen
characteristics are important, aspects of the host population play
a significant role in the success of bacterial lineages.
At a whole genome level, ST93 can be considered the earliest
diverging of currently sampled S. aureus lineages. We found
evidence that recombination has played a significant role in
the evolutionary history of ST93 with large proportions of the
genome derived from highly divergent sequences and other
segments from ancestors related to the ST59/ST121 clade of
S. aureus. Somewhat at odds with this ancient history is that the
currently extant ST93 population has limited genetic diversity
with a most recent common ancestor from the 1970s.
The current ST93 population has rapidly become established
in geographically disparate remote regions of the Northern
Territory and Western Australia with largely Indigenous
Australian populations. In a survey of Indigenous Australian
residents from remote communities in northern Western
Australia from 1996 to 2003, the most common lineage isolated
was ST93-MSSA (O’Brien et al., 2009). Broader epidemiological
studies with an unbiased sampling of both MSSA and MRSA in
Australia concur with a substantial presence of ST93-MSSA in
the Northern Territory (Tong et al., 2010) and Western Australia
(O’Brien et al., 2009) and its near absence in other parts of
Australia (Holmes et al., 2014). A possible interpretation of our
results is that ST93, with genomic regions derived from an early
diverging population of S. aureus, has been carried in isolation by
Indigenous Australians, also an early diverging population within
Homo sapiens (Malaspinas et al., 2016). However, the dating of
the emergence of ST93 to the 1970s is inconsistent with this
model unless there was a tight bottleneck in the 1970s leading to
a marked reduction in diversity of ST93. An alternative scenario
is that the expansion of ST93 in humans followed a cross-species
transfer event from a yet to be identified non-human reservoir.
The recent expansion and establishment of a S. aureus
clone may be somewhat surprising given the overall sparseness
of population in these regions; the Northern Territory has a
population density of 0.2 person per km2, and the Kimberley
region in the north of Western Australia <0.1 person per
km2, compared to 2.9 and 269 people per km2 for Australia
and the United Kingdom, respectively. Notably, the Northern
Territory and Kimberley, Western Australia have among the
highest proportions of Indigenous people as part of the
population in Australia at 26% (and 51% if excluding the urban
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center of Darwin) and 41%, respectively. There is documented
overcrowding within remote community households with a
median of 7 and up to 23 residents per household (Vino et al.,
2017) and a high prevalence of SSTI (an estimated 45% of
remote living Indigenous children from the Northern Territory,
Western Australia and Queensland suffer from impetigo at any
one point in time) (Bowen et al., 2015), facilitating the spread
and amplification of local emerging S. aureus clones. Studies
in the United States and United Kingdom have highlighted the
importance of household transmission and markers of socio-
economic deprivation to the transmission of CA-MRSA lineages
(Knox et al., 2015; Tosas Auguet et al., 2016).
Strikingly, ST93-MRSA-IVa was not detected in Western
Australia until 2003. However, since then ST93-MRSA-IVa has
become the dominant CA-MRSA in Western Australia, with a
focus in the north-west of the state, particularly the Kimberley
region where ST93-MRSA has been isolated at a rate of 2,499
isolations per 100,000 population in 2015–2016 (compared to
41 isolations per 100,000 population in the metropolitan region
around the capital Perth) (Coombs et al., 2017). As with the
emergence of ST93-MSSA, it is likely that socio-demographic
factors play an important role in this rapid expansion of ST93-
MRSA-IVa.
Following its emergence in north-western Australia, ST93-
MRSA-IVa became endemic in Australia, and then was
transmitted from the Australian eastern seaboard to the
United Kingdom and New Zealand. Similar to patterns seen with
USA300 (Bouchiat et al., 2017) and ST80 (Stegger et al., 2014),
inter-country transmission has not led to continued transmission
and endemicity of ST93-MRSA-IVa in the United Kingdom.
In contrast, we have demonstrated establishment of ST93-
MRSA-IVa in New Zealand, centered primarily in the Auckland
region and in the Pacific Islander population. Ma¯ori and
Pacific Islanders made up 65% of New Zealand ST93-MRSA-
IVa infections and are thus clearly over-represented in light of
these population groups representing 15 and 7%, respectively of
the general New Zealand population. Notably, rates of S. aureus
skin infections and CA-MRSA infections are significantly higher
in Mâori and Pacific Islander populations in New Zealand
compared to patients of European ethnicity (Williamson et al.,
2013, 2014). The reasons for this association are multifactorial,
but are likely to include a combination of poverty and domestic
overcrowding – i.e., similar socio-demographic conditions to
those favoring the emergence of ST93 in north-western Australia
(Williamson et al., 2013, 2014). These data may explain why other
CA-MRSA lineages remain currently geographically restricted,
despite numerous intercontinental transfer events, as incursion
events are not usually occurring into a vulnerable population.
CONCLUSION
ST93 is an early diverging lineage of currently sampled S. aureus
lineages, with a genome shaped by recombination and of which
large proportions are derived from highly divergent sequences.
The evolutionary history of ST93 suggests the importance of host
population characteristics on both the emergence and ongoing
spread of CA-MRSA lineages. Understanding this interplay better
would enable interventions at controlling these clones to be
refined.
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FIGURE S1 | Recombinant regions across Staphylococcus aureus as detected by
Gubbins. Maximum-likelihood cladograms (RAxML, GTR+G) of the
progressiveMauve (2,157,328 sites, 358,325 SNPs) core alignment after removing
recombinant segments (blocks). Recombinant segments were filtered by length as
indicated and represent shared ancestral events (red) and events unique to
terminal branches (blue). Large segments spanning the origin of replication are
present in the ST239/ST240 lineage, while smaller events are particularly common
in S. argenteus and lineages ST22, ST93, ST152, and ST395.
FIGURE S2 | Terminal recombination events. Terminal recombination events
(unique to each sequence type) detected with Gubbins in the progressiveMauve
core genome alignment (2,157,328 sites). (A) Length distribution of unique
recombinant events demonstrating a majority of short recombination events
(average: 2,209 base pairs) detected in ST93. (B) Total base pairs of
non-overlapping recombinant events ancestrally shared (red) or unique (blue)
across sequence types in our data set. ST93 (top) features the largest number of
unique recombinant sites compared to other sequence types. (C) Ratio (r/m) of
base substitutions predicted to have been imported through recombination (r) to
those occurring through point mutations (m), showing only sequence types with
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unique (terminal) recombination events on their respective branch of the phylogeny
inferred with Gubbins. Thus, there is a strong influence of recombination on the
variation accumulated in ST93. (D) Ratio (rho/theta) of the number of
recombination events (rho) to point mutations, showing a comparatively high rate
of recombination in the core genome relative to mutation for ST93.
FIGURE S3 | Additional pair-wise nucleotide divergence comparisons between
representative S. aureus genomes including ST93. Pair-wise nucleotide
divergence across a 10,000 bp sliding window along the S. aureus core genome
with comparisons between ST59-ST121, ST93-ST59, ST93-ST8, ST59-ST8, and
ST8-ST5. Bases affected by recombination as detected by Gubbins across the
ST93 genome are represented above with shared ancestral events (red) and
events unique to the ST93 terminal branch (blue). Terminal branch recombination
regions align with genomic positions where ST93 is highly diverged compared to
other S. aureus.
FIGURE S4 | Source of isolates. (A) Depicts the location from where the isolates
originated with red boxes representing states and territories of Australia. European
countries include England (n = 45), Scotland (n = 12), Denmark (n = 4), France
(n = 1), and Italy (n = 1). Note, Samoan isolates (n = 4) are not depicted. The
number of MSSA isolates sequenced, by location are shown on the secondary
axis by the blue line. (B) Represents the temporal distribution of the isolates
with the number of blood stream isolates depicted by the red bars on the
secondary axis. Note that data on source of infection was unknown for 52
isolates.
FIGURE S5 | Evidence of short transmission chains in the United Kingdom.
Maximum clade credibility tree as in Figure 1, but with transmission chains from
the United Kingdom highlighted. Box 1 – four isolates from three individuals of
which two were siblings. Box 2 – three isolates from separate patients in same
pediatric hospital. Box 3 – there were no obvious epidemiological links with cases
geographically widely distributed. Box 4 – there were no obvious epidemiological
links.
FIGURE S6 | Proportion of methicillin-resistant Staphylococcus aureus that are
ST93-MRSA. This represents longitudinal data of ongoing MRSA typing data from
Australia, New Zealand (NZ) and United Kingdom (UK). Graph depicts the
percentage of MRSA isolates that are ST93 between 2008 and 2015. Data were
obtained from Public Health England, United Kingdom, the Institute of
Environmental Science and Research, New Zealand, and the Australian
Collaborating Centre for Enterococcus and Staphylococcus Species (ACCESS)
Typing and Research, Australia.
FIGURE S7 | Network clusters of ST93. (A) General network clusters using the
low-resolution fast-greedy modularity optimization algorithm. (B) Cluster
assignments were mapped back to the phylogeny.
TABLE S1 | Details of 459 ST93 Staphylococcus aureus genomes.
TABLE S2 | Details of Staphylococcus aureus genomes used to determine
phylogenetic position of ST93.
TABLE S3 | Coding sequences in highly divergent regions of ST93. The
divergence peaks in Figure 1 were determined using a sliding window of
10,000 bp to assess divergence between the pairwise combinations of sequence
types. These annotated genes are extracted from each plateau (i.e., 10,000 bp of
divergent peak) and from pairwise combinations involving ST93 where >0.05
divergence was noted.
TABLE S4 | Non-synonymous mutations restricted to the branch defining the
New Zealand clade.
TABLE S5 | Pan-genome details from Roary output.
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